effect of at scale drug provision in a poor country, using the phased roll-out of ART in Zambia, a setting where …

, such as quality or price. An attribute is salient for a good when it stands out among the good's characteristics, in the … are characterized by only one quality attribute and price, salience tilts choices toward goods with higher ratios of … quality to price. We use the model to account for a variety of disparate bits of evidence, including decoy effects in consumer …

efficiency. We distinguish countries with and without universal insurance, because insurance undermines patients' price … for health; manufacturers price to that ICER threshold; and payers limit reimbursement to patients for whom a drug is cost …-effective at that price and ICER, then the resulting price levels and use within each country and price differentials across …

companies based on their vulnerability to future price regulation. We then consider patterns in price movements across companies … their corporate Political Action Committees (PACs) slowed price increases during 1992 and 1994 more than their competitors … to keep price increases below the rate of inflation …

their best (lowest) price in some cases, a percentage below average price in others. Many theoretical models have shown that … product's characteristics match the incentives in the law. I find that after the MFC rule was implemented the average price of … branded products facing generic competition rose - the median presentation's price rose about 4%. Brands protected by patents …

roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we … estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 … increase after entry and are accompanied by large price decreases in the price of generic drugs …

agencies and private organizations all conducting investigations into the pricing patterns for generic drugs. Price spikes for … selected old, off-patent drugs have also been widely reported in the media. To place these generic price increases into context …, we construct two chained Laspeyres consumer price indexes (CPIs), using the 2007-2016 IBM MarketScan Commercial Claims …

equilibrium price effects of coupons, we employ individual-level data to estimate a discrete choice model of demand for multiple … sclerosis drugs. We use our demand estimates to parameterize a model of drug price negotiations. For this category of drugs, we …

of broadcast and non-broadcast DTCA on price and demand, utilizing an extended time series of monthly records for all … models suggest that broadcast DTCA positively impacts own-sales and price, with an estimated elasticity of 0.10 and 0 ….04 respectively. Relative to broadcast DTCA, non-broadcast DTCA has a smaller impact on sales (elasticity of 0.05) and price …